TABLE 2.
CHARACTERISTICS OF PATIENTS WITH NORMAL PRETREATMENT CA-125
Distribution of 99 Patients with Normal Pretreatment CA-125 | Percentage of Patients in Each Subgroup with Normal Pretreatment CA-125 | |
---|---|---|
Stage | ||
III- optimal microscopic | 40.4% | 16.0% |
III- optimal gross | 39.3% | 8.8% |
III- suboptimal | 15.2% | 3.6% |
IV | 5.1% | 2.7% |
Histologic Subtype | ||
Serous | 64.6% | 6.8% |
Endometrioid | 6.1% | 5.2% |
Mucinous | 8.1% | 30.8% |
Clear Cell | 3.0% | 8.1% |
Other | 18.2% | 9.8% |